Clinical Trial ID: NCT04762069
A Multicenter, Open-Label Study With a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV) After Failure of Standard First Line Therapy
Status
Open
Conditions
Other
Phases
III
Age Group
Adult
Main Investiagtor
Cavaliere, Robert
Practice
CNS
Scope
National
Participating Institutions
Baptist MD Anderson Cancer Center
Nct ID Number
NCT04762069
Secondary Trial ID Number
CNS-201
Keywords
Treatment